Townsend Adam J.

Related Filers (1)

Other (7)

144
Monday, 2/12/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/29/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/22/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/16/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 12/1/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 5/3/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 4/3/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (31)

4
Tuesday, 2/13/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/31/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/23/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/17/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/5/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/4/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/5/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/7/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/6/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/7/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/7/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/5/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/7/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/16/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/12/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/9/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/4/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/12/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/1/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/11/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/1/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/12/2020
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 4/15/2019
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Show More